Habitual physical activity, such as walking or gardening, may decrease fasting GLP-1 concentrations and increase glucose-stimulated GLP-1 responses independent of insulin sensitivity.
The American Diabetes Association (ADA) has published an update to their Standards of Medical Care in Diabetes for 2020.
Sleep may be an important modifiable factor in disease management in patients with type 2 diabetes, especially variation in sleep duration.
A hospital-based cohort study found sex heterogeneity in the severity of osteoarthritis symptoms in type 2 diabetes, and an association between insulin treatment and pain severity in men.
Daily liraglutide, in addition to metformin and insulin, reduces HbA1c and improves glycemic control in young patients with type 2 diabetes.
Changes in cardiovascular health over time may affect risk for type 2 diabetes and impaired fasting glucose.
Researchers found that significant improvement in symptoms of posttraumatic stress disorder is associated with a lower risk for type 2 diabetes among veterans.
The AACE has produced a position statement addressing population-specific challenges and practical steps for clinicians with regard to diabetes care for African Americans, Latinx/Hispanics, Asian Americans, and Native Americans.
The Endocrine Society published a clinical practice guideline cosponsored by the American Diabetes Association and the European Society of Endocrinology regarding the primary prevention of ASCVD and T2D.
The FDA has accepted for review the New Drug Application for an investigational triple combination tablet for the treatment of adults with type 2 diabetes.
